A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma.
Zhong L, Fu XY, Zou C, Yang LL, Zhou S, Yang J, Tang Y, Cheng C, Li LL, Xiang R, Chen LJ, Chen YZ, Wei YQ, Yang SY.
Zhong L, et al. Among authors: yang sy, yang ll, yang j.
Int J Cancer. 2014 Dec 15;135(12):2972-83. doi: 10.1002/ijc.28944. Epub 2014 May 12.
Int J Cancer. 2014.
PMID: 24789676